Motor Neurone Disease Trial, Recruiting NCT06429735 Sponsor: Neuralink Corp Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT06429735
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have severe paralysis of both arms and legs (called quadriplegia or tetraplegia) caused by either a spinal cord injury or ALS, with very little or no movement in your hands, wrists, and arms, and this has been the case for at least 1 year with no improvement
  • Doctors expect you to live for at least 12 more months
  • You are able to communicate in English
  • You have a reliable caregiver who is consistently available to support you

Who may not be able to join:

  • You have health conditions that would make surgery risky for you
  • You have any active implanted medical devices (such as a pacemaker)
  • Your Body Mass Index (BMI) is over 40, which doctors classify as morbid obesity
  • You have a history of seizures or epilepsy that has been difficult to control
  • You have a history of diabetes that has been difficult to control
  • You need MRI (magnetic resonance imaging) scans as part of managing an ongoing health condition
  • You have a weakened immune system, either from a condition you were born with or one you developed
  • You currently use cigarettes, tobacco, or any other tobacco products
  • You have a diagnosed psychiatric or psychological condition
  • A brain MRI scan has shown bleeding, a tumor, or unusual or abnormal brain structure
  • You have any other condition that, in the opinion of the research team, could make it unsafe for you to take part in the study or undergo the implant procedure (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Francisco Ponce, MD, Barrow Neurological Institute

Phone: (877) 398-4465

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Neuralink Corp
Registry
ClinicalTrials.gov
Start date
9 January 2024
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Device-Related Adverse Events (AE); Procedure-Related Adverse Events (AE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov